Literature DB >> 2783494

Recurrence of colorectal tumors: PET evaluation.

L G Strauss1, J H Clorius, P Schlag, B Lehner, B Kimmig, R Engenhart, M Marin-Grez, F Helus, F Oberdorfer, P Schmidlin.   

Abstract

Positron emission tomography (PET) was used in the follow-up of patients with colorectal malignancies to differentiate between recurrent colorectal tumor and scar. Patients were examined with oxygen-15-labeled water and with fluorine-18-labeled deoxyglucose (FDG). FDG was injected intravenously to assess tumor metabolism. The tracer concentration was quantitatively evaluated by means of a region-of-interest technique and standardized for both injected dose and body volume. Of 29 patients, 21 had recurrent colorectal malignancy, and eight had a nonmalignant mass. All malignancies were seen on the PET cross sections. Nonmalignant lesions had a low FDG accumulation on images obtained 60 minutes after injection. While the tumor-soft tissue ratio was highest shortly after the intravenous injection of FDG, the tumor-scar ratio was highest 60 minutes after injection. It was possible to differentiate tumor from non-malignant tissue with FDG with the use of standardized concentration values and tumor-soft tissue ratios. Imaging with O-15-labeled water gave no additional information.

Entities:  

Mesh:

Year:  1989        PMID: 2783494     DOI: 10.1148/radiology.170.2.2783494

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  31 in total

1.  Cancer treatment monitoring with fluorine-18 2-fluoro-2-deoxy-D-glucose and positron emission tomography: frustration or future.

Authors:  H Minn; R Paul
Journal:  Eur J Nucl Med       Date:  1992

2.  Local recurrence of rectosigmoid cancer: what about the choice of MRI for diagnosis?

Authors:  L Balzarini; E Ceglia; G D'Ippolito; R Petrillo; J D Tess; R Musumeci
Journal:  Gastrointest Radiol       Date:  1990

3.  Can PET-CT with FDG replace contrast enhanced CT for imaging of liver metastases?

Authors:  Ludwig G Strauss; Antonia Dimitrakopoulou-Strauss
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-12       Impact factor: 9.236

4.  PET reflections.

Authors:  U Buell
Journal:  Eur J Nucl Med       Date:  1991

5.  Peritoneal recurrence of colon cancer detected by positron emission tomography: report of a case.

Authors:  S Yasuda; H Makuuchi; S Sadahiro; M Mukai; H Ishida; N Tokunaga; T Kimura; T Tajima; A Shohtsu
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

6.  A clinical evaluation of FDG-PET to assess the response in radiation therapy for bronchogenic carcinoma.

Authors:  Y Ichiya; Y Kuwabara; M Sasaki; T Yoshida; J Omagari; Y Akashi; A Kawashima; T Fukumura; K Masuda
Journal:  Ann Nucl Med       Date:  1996-05       Impact factor: 2.668

7.  Diagnostic performance of MDCT, PET/CT and gadoxetic acid (Primovist(®))-enhanced MRI in patients with colorectal liver metastases being considered for hepatic resection: initial experience in a single centre.

Authors:  V O Chan; J P Das; J F Gerstenmaier; J Geoghegan; R G Gibney; C D Collins; S J Skehan; D E Malone
Journal:  Ir J Med Sci       Date:  2012-03-17       Impact factor: 1.568

8.  Evaluation of tumour metabolism and multidrug resistance in patients with treated malignant lymphomas.

Authors:  A Dimitrakopoulou-Strauss; L G Strauss; H Goldschmidt; W J Lorenz; W Maier-Borst; G van Kaick
Journal:  Eur J Nucl Med       Date:  1995-05

9.  Application of whole-body positron emission tomography in the imaging of esophageal cancer: report of a case.

Authors:  S Yasuda; S Raja; K F Hubner
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

10.  Thoracic recurrence in patients with curatively-resected colorectal cancer: incidence, risk factors, and value of chest CT as a postoperative surveillance tool.

Authors:  J H Lee; Chang Min Park; I Joo; Y J Suh; E J Hwang; H Kim; J M Goo
Journal:  Eur Radiol       Date:  2018-10-22       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.